The Journey of Symptoms: More Than Just Kidneys
At a Glance
Alport syndrome is a progressive genetic condition that follows a predictable pattern of symptoms. Early signs typically begin with microscopic blood and protein in the urine, often followed by high-frequency hearing loss and distinctive eye changes as the disease progresses.
Alport syndrome is a progressive condition, meaning it changes over time. While the primary concern is the kidneys, the disease often leaves a distinctive trail of clues in the ears and eyes. Understanding the “typical” sequence of these signs can help you and your medical team monitor your health more effectively.
The Kidney Journey: From Early Signs to Progression
The progression of Alport syndrome usually follows a predictable pattern, though the speed varies greatly depending on your genetic subtype [1][2].
- Microscopic Hematuria: The earliest sign is often blood in the urine (hematuria). This is typically “microscopic,” meaning it can only be seen under a microscope. It often appears in early childhood [2].
- Proteinuria: As the kidney filters (glomeruli) weaken, they begin to leak protein into the urine (proteinuria). This is a critical milestone because higher levels of protein are linked to a faster decline in kidney function [3].
- Declining Kidney Function: Over time, the constant stress and leakage cause scarring in the kidneys. This reduces their ability to filter waste, eventually leading to chronic kidney disease and, for many, end-stage renal disease (ESRD) [1]. Note that kidney function is often monitored by “stages” (Stage 1 to 5), with Stage 5 representing kidney failure.
Progression by Genetic Type
- ARAS (Autosomal Recessive): Generally shows the most rapid progression. Many individuals reach kidney failure in their late teens or early 20s [1][2].
- XLAS (X-linked) Males: Progression is typically steady, often leading to kidney failure by age 30, though new treatments are extending this timeline [4].
- XLAS Females & ADAS (Autosomal Dominant): These forms are highly variable. While some may never experience kidney failure, others do, and the risk increases if protein levels in the urine are not managed early [3][5].
Hearing Loss: A “High-Frequency” Clue
One of the most common signs outside the kidneys is sensorineural hearing loss (SNHL). This is not a problem with the outer ear, but with the tiny hair cells in the inner ear that also rely on Type IV Collagen [6].
- Pattern: The hearing loss usually affects “high-frequency” sounds first—like bird chirps or the “s” and “f” sounds in speech. This makes it hard to understand conversations in noisy environments [7].
- Timing: It rarely exists at birth. Instead, it typically presents in late childhood or early adolescence, often around the same time kidney function begins to decline [2][7].
- Management: It is important to note that blood pressure medications (like ACE inhibitors) do not prevent or treat this hearing loss. However, hearing aids are highly effective and are the standard treatment [7].
Ocular Manifestations: The Window to Diagnosis
Alport syndrome can cause several unique changes in the eyes. While these rarely cause total blindness, they are powerful diagnostic tools for doctors [8][9].
- Anterior Lenticonus: The lens of the eye becomes cone-shaped rather than round. This can cause worsening nearsightedness and is a hallmark sign of Alport syndrome [10][11].
- Maculopathy (Retinopathy): Doctors may see specific patterns of white or yellow flecks on the retina, sometimes described as honeycomb or staircase patterns. These usually do not affect vision but are strong indicators of the disease [12][13].
- Retinal Thinning: Advanced imaging like OCT (Optical Coherence Tomography) can detect thinning of the retina, which can be an early indicator of Alport syndrome even before other symptoms appear [8][14].
Monitoring these “extra-renal” signs is not just about vision and hearing; they serve as a barometer for the disease itself. Regular screenings with an audiologist and an ophthalmologist are essential parts of your care team [8][15].
Common questions in this guide
What are the first signs of Alport syndrome?
Does Alport syndrome cause hearing loss?
How does Alport syndrome affect the eyes?
How fast does Alport syndrome progress?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How often should we screen for protein in the urine, and what level of proteinuria is a trigger for starting medication?
- 2.Given our family's genetic subtype, what is the 'typical' age range for hearing changes to begin?
- 3.Can you recommend an ophthalmologist who is familiar with 'anterior lenticonus' and Alport-related maculopathy?
- 4.How often should we repeat hearing and vision screenings if the first ones are normal?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (15)
- 1
Clinical, histological and molecular characteristics of Alport syndrome in Chinese children.
Zhou L, Xi B, Xu Y, et al.
Journal of nephrology 2023; (36(5)):1415-1423 doi:10.1007/s40620-023-01570-7.
PMID: 37097554 - 2
Features of Autosomal Recessive Alport Syndrome: A Systematic Review.
Lee JM, Nozu K, Choi DE, et al.
Journal of clinical medicine 2019; (8(2)) doi:10.3390/jcm8020178.
PMID: 30717457 - 3
A Systematic Review of Pathogenic COL4A5 Variants and Proteinuria in Women and Girls With X-linked Alport Syndrome.
Gibson JT, de Gooyer M, Huang M, Savige J
Kidney international reports 2022; (7(11)):2454-2461 doi:10.1016/j.ekir.2022.08.021.
PMID: 36531881 - 4
Genotype-Phenotype Correlations for Pathogenic COL4A3-COL4A5 Variants in X-Linked, Autosomal Recessive, and Autosomal Dominant Alport Syndrome.
Savige J, Huang M, Croos Dabrera MS, et al.
Frontiers in medicine 2022; (9()):865034 doi:10.3389/fmed.2022.865034.
PMID: 35602506 - 5
Glomerular Basement Membrane Protein Expression and the Diagnosis and Prognosis of Autosomal Dominant Alport Syndrome.
Akihisa T, Sato M, Wakayama Y, et al.
Kidney medicine 2019; (1(6)):391-396 doi:10.1016/j.xkme.2019.06.007.
PMID: 32734219 - 6
Genotype-phenotype correlations for COL4A3-COL4A5 variants resulting in Gly substitutions in Alport syndrome.
Gibson JT, Huang M, Shenelli Croos Dabrera M, et al.
Scientific reports 2022; (12(1)):2722 doi:10.1038/s41598-022-06525-9.
PMID: 35177655 - 7
Hearing Evaluation in Patients with Chronic Renal Failure: A 1 Year Cross-Sectional Study in a Tertiary Care Centre.
Mudhol RS, Jahnavi
Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India 2019; (71(Suppl 2)):1633-1638 doi:10.1007/s12070-019-01701-2.
PMID: 31750229 - 8
Ocular Manifestations of Alport Syndrome: Report and Comparison of Two Cases.
Sargazi M, Dehghani S, Dahmardeh M, Mohammadi SO
Cureus 2023; (15(10)):e47373 doi:10.7759/cureus.47373.
PMID: 38022159 - 9
[Alport syndrome. Report of two cases].
Jones A, Gallegos M, Díaz I, et al.
Revista medica de Chile 2019; (147(4)):522-526 doi:10.4067/S0034-98872019000400522.
PMID: 31344217 - 10
Bilateral giant macular holes: A rare manifestation of Alport syndrome.
Raimundo M, Fonseca C, Silva R, Figueira J
European journal of ophthalmology 2019; (29(1)):NP13-NP16 doi:10.1177/1120672118781232.
PMID: 29873249 - 11
Femtosecond laser-assisted cataract surgery in anterior lenticonus due to Alport syndrome.
Barnes AC, Roth AS
American journal of ophthalmology case reports 2017; (6()):64-66 doi:10.1016/j.ajoc.2017.03.004.
PMID: 29260061 - 12
Stair-Case/Honeycomb Maculopathy in Alport Syndrome: A Case Report.
Rustam Z, Aman S, Singh N, et al.
Case reports in ophthalmology 2025; (16(1)):496-502 doi:10.1159/000546567.
PMID: 40666795 - 13
MACULAR HOLES, VITELLIFORM LESIONS, AND MIDPERIPHERAL RETINOSCHISIS IN ALPORT SYNDROME.
Thomas AS, Baynham JT, Flaxel CJ
Retinal cases & brief reports 2016; (10(2)):109-11 doi:10.1097/ICB.0000000000000176.
PMID: 26200386 - 14
Phacoemulsification in bilateral anterior lenticonus in Alport syndrome: A case report.
Sedaghat MR, Momeni-Moghaddam H, Haghighi B, Moshirfar M
Medicine 2019; (98(39)):e17054 doi:10.1097/MD.0000000000017054.
PMID: 31574802 - 15
Genotype-phenotype correlations influence the response to angiotensin-targeting drugs in Japanese patients with male X-linked Alport syndrome.
Yamamura T, Horinouchi T, Nagano C, et al.
Kidney international 2020; (98(6)):1605-1614 doi:10.1016/j.kint.2020.06.038.
PMID: 32712167
This page provides educational information about the progression of Alport syndrome symptoms. Always consult your nephrologist, audiologist, and ophthalmologist for monitoring and managing your specific condition.
Get notified when new evidence is published on Alport syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.